O'Toole L - Search Results

1

Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.

Vujosevic S, Parra MM, Hartnett ME, O'Toole L, Nuzzi A, Limoli C, Villani E, Nucci P. Vujosevic S, et al. Eye (Lond). 2023 Feb;37(2):203-219. doi: 10.1038/s41433-022-02056-9. Epub 2022 Apr 15. Eye (Lond). 2023. PMID: 35428871 Free PMC article. Review.

2

OUTCOMES OF SWITCHING FROM PROACTIVE TO REACTIVE TREATMENT AFTER DEVELOPING ADVANCED CENTRAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Cornish EE, Nguyen V, Puzo M, O'Toole L, Gemmy Cheung CM, Vincent A, Guillaumie T, Oei SL, Morros HB, Barthelmes D, Gillies MC. Cornish EE, et al. Retina. 2023 Jul 1;43(7):1070-1080. doi: 10.1097/IAE.0000000000003771. Retina. 2023. PMID: 36893432

3

The Effect on Patients' Visual Acuity and Grade, Secondary to Non-Attendance at Treatment Centers, Post Referral from Diabetic RetinaScreen Ireland.

Harmon J, Kelly S, Acheson R, Keegan D, McMahon S, Kavanagh H, O'Toole L. Harmon J, et al. Clin Ophthalmol. 2023 Jan 11;17:183-190. doi: 10.2147/OPTH.S388988. eCollection 2023. Clin Ophthalmol. 2023. PMID: 36660306 Free PMC article.

4

Correction: Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children.

Vujosevic S, Parra MM, Hartnett ME, O'Toole L, Nuzzi A, Limoli C, Villani E, Nucci P. Vujosevic S, et al. Eye (Lond). 2023 Feb;37(2):379. doi: 10.1038/s41433-022-02083-6. Eye (Lond). 2023. PMID: 35550606 Free PMC article. No abstract available.

5

European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Boudousq C, Nguyen V, Hunt A, Gillies M, Zarranz-Ventura J, O'Toole L, Mangelschots E, Kusenda P, Schmidt-Erfurdt U, Pollreisz A, Kheir WJ, Arruabarrena C, Vujosevic S, Barthelmes D, Creuzot-Garcher C, Gabrielle PH. Boudousq C, et al. Among authors: o toole l. Ophthalmol Retina. 2024 Jan 6:S2468-6530(24)00006-X. doi: 10.1016/j.oret.2024.01.004. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38185453 Free article.

6

Imaging geographic atrophy: integrating structure and function to better understand the effects of new treatments.

Vujosevic S, Loewenstein A, O'Toole L, Schmidt-Erfurth UM, Zur D, Chakravarthy U. Vujosevic S, et al. Among authors: o toole l. Br J Ophthalmol. 2024 Jan 30:bjo-2023-324246. doi: 10.1136/bjo-2023-324246. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38290804 Review.

7

Clinical Features Related to OCT Angiography Artifacts in Patients with Diabetic Macular Edema.

Tamer Kaderli S, Piccoli G, Limoli C, Ginelli S, Caboni S, Brotto L, Torti E, O'Toole L, Nucci P, Vujosevic S. Tamer Kaderli S, et al. Among authors: o toole l. Ophthalmol Retina. 2024 Mar 4:S2468-6530(24)00089-7. doi: 10.1016/j.oret.2024.02.017. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38447922

8

One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry.

Mehta H, Gabrielle PH, Hashimoto Y, Kibret GD, Arnold J, Guillaumie T, Kheir WJ, Kok G, Vujosevic S, O'Toole L, Mangelschots E, Jaross N, Ceklic L, Daien V, Viola F, Squirrell D, Lavid FJ, Creuzot-Garcher C, Barthelmes D, Gillies M; Fight Retinal Blindness! Study Group. Mehta H, et al. Among authors: o toole l. Ophthalmol Retina. 2024 Apr 12:S2468-6530(24)00182-9. doi: 10.1016/j.oret.2024.04.008. Online ahead of print. Ophthalmol Retina. 2024. PMID: 38615818 Free article.

9

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration.

Teo KYC, Nguyen V, O'Toole L, Daien V, Sanchez-Monroy J, Ricci F, Ponsioen TL, Morros HB, Cheung CMG, Arnold JJ, Barthelmes D, Gillies MC. Teo KYC, et al. Eye (Lond). 2023 Feb;37(3):467-473. doi: 10.1038/s41433-022-01957-z. Epub 2022 Feb 9. Eye (Lond). 2023. PMID: 35140329 Free PMC article.

10

Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.

Gabrielle PH, Nguyen V, Arnould L, Viola F, Zarranz-Ventura J, Barthelmes D, Creuzot-Garcher C, Gillies M; Fight Retinal Blindness! Study Group. Gabrielle PH, et al. Ophthalmol Retina. 2022 Nov;6(11):1044-1053. doi: 10.1016/j.oret.2022.05.008. Epub 2022 May 16. Ophthalmol Retina. 2022. PMID: 35589075 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page